15.24

4.75% -0.76

After Hours: 15.24

Apollomics Inc (APLM)

Overview News Price History Why APLM Down? Discussions Forecast

Apollomics Inc stock is traded at $15.24, with a volume of 3,230. It is down -4.75% in the last 24 hours and up +8.86% over the past month. Apollomics Inc is an clinical-stage biopharmaceutical company focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company programs include vebreltinib (APL-101), a potent, selective c-Met inhibitor for the treatment of non-small cell lung cancer and other tumors with c-Met alterations, and uproleselan (APL-106), a specific E-Selectin antagonist that has the potential to be used adjunctively with standard chemotherapy to treat acute myeloid leukemia.

Previous Close:

$16.00

Open:

$15.44

24h Volume:

3,230

Relative Volume:

0.37

Market Cap:

$33.47M

Revenue:

$8.50M

Net Income/Loss:

$-10.94M

P/E Ratio:

-2.0132

EPS:

-7.57

Net Cash Flow:

$-28.76M

1W Performance:

+16.56%

1M Performance:

+8.86%

6M Performance:

+14.41%

1Y Performance:

+150.25%

1-Day Range:

$15.24

$15.59

1-Week Range:

$13.00

$17.00

52-Week Range:

$3.659

$42.12

Apollomics Inc Stock (APLM) Company Profile

Name

Apollomics Inc

Sector

Healthcare (1111)

Industry

Biotechnology (621)

Phone

Address

Employee

Twitter

Next Earnings Date

2026-04-02

Latest SEC Filings

APLM's Discussions on Twitter

Compare APLM vs VRTX, REGN, ARGX, ALNY, ONC

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
APLM Apollomics Inc	15.24	35.14M	8.50M	-10.94M	-28.76M	-7.57
VRTX Vertex Pharmaceuticals Inc	427.65	107.87B	12.32B	4.34B	3.19B	16.86
REGN Regeneron Pharmaceuticals Inc	721.05	73.63B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	807.55	49.42B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	303.00	40.20B	3.71B	313.75M	465.38M	2.2571
ONC Beone Medicines Ltd Adr	313.32	33.06B	5.36B	287.73M	924.18M	2.5229

Apollomics Inc Stock (APLM) Latest News

May 01, 2026

APLMW | Apollomics Inc. Warrant Insider Trading - Quiver Quantitative

May 01, 2026

Apr 29, 2026

Is Apollomics (APLMW) dividend sustainable? (Smart Money Exits) 2026-04-29Crowd Sentiment Stocks - Newser

Apr 29, 2026

Apr 27, 2026

Apollomics (Nasdaq: APLM) slashes 2025 loss amid cost cuts and new vebreltinib deal revenue - Stock Titan

Apr 27, 2026

Over 282 subjects enrolled as Apollomics targets 2027 U.S. filing - Stock Titan

Apr 27, 2026

How Apollomics Inc. (APLM) Affects Rotational Strategy Timing - Stock Traders Daily

Apr 27, 2026

APLM Apollomics highlights oncology pipeline progress and upcoming clinical trial milestones in its latest quarterly earnings report.Gamma Squeeze - Newser

Apr 27, 2026

Apr 24, 2026

APLM: Strategic restructuring and licensing revenue reduced losses, but liquidity and going concern risks persist - TradingView

Apr 24, 2026

Apollomics (NASDAQ: APLM) warns on going concern, defers vebreltinib NDA and writes down asset - Stock Titan

Apr 24, 2026

Apollomics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com

Apr 24, 2026

Apr 21, 2026

Apollomics (APLM) Stock: Is It a Smart Investment (Slight Loss) 2026-04-18Crowd Entry Signals - Cổng thông tin điện tử tỉnh Lào Cai

Apr 19, 2026

Apr 18, 2026

Hong Jung Chen Net Worth (2026) - GuruFocus

Apr 18, 2026

Ya Chi Huang Net Worth (2026) - GuruFocus

Apr 18, 2026

Apr 17, 2026

Peter Kuan How Lin Net Worth (2026) - GuruFocus

Apr 17, 2026

Yi Kuei Chen Net Worth (2026) - GuruFocus

Apr 17, 2026

Chen Huan Jan Net Worth (2026) - GuruFocus

Apr 17, 2026

Hsien Shu Tsai Net Worth (2026) - GuruFocus

Apr 17, 2026

Apollomics (APLM) director details RSUs, options and warrants in Form 3/A - Stock Titan

Apr 17, 2026

Apollomics (APLM) CFO has shares withheld for RSU tax obligations - Stock Titan

Apr 17, 2026

Apr 16, 2026

(APLM) and the Role of Price-Sensitive Allocations - Stock Traders Daily

Apr 16, 2026

Apr 14, 2026

[Form 3/A] Apollomics Inc. Amended Initial Statement of Beneficial Ownership - Stock Titan

Apr 14, 2026

Apollomics (APLM) director Jan Chen-Huan reports 1,000 RSUs and 1,000 shares - Stock Titan

Apr 14, 2026

Apollomics (APLM) CFO details 20,000 RSUs and 15,900 shares in Form 3/A - Stock Titan

Apr 14, 2026

Apollomics (ticker: APLM) CEO details direct and indirect share stakes - Stock Titan

Apr 14, 2026

Apollomics (APLM) director discloses 1,000 restricted stock units award - Stock Titan

Apr 14, 2026

Apollomics (APLM) COO details RSU grants and Maxpro warrant stakes - Stock Titan

Apr 14, 2026

Apollomics (APLM) director Huang Ya-Chi details RSU vesting and share holdings - Stock Titan

Apr 14, 2026

Apr 13, 2026

Tech Rally: Does Apollomics Inc Equity Warrant have pricing power2026 PreEarnings & Fast Entry Momentum Alerts - baoquankhu1.vn

Apr 13, 2026

Market Outlook: Is Apollomics Inc in a consolidation phase2026 Bull vs Bear & AI Optimized Trading Strategy Guides - baoquankhu1.vn

Apr 13, 2026

Bear Alert: Can Apollomics Inc stock outperform in a bear marketWeekly Stock Analysis & Safe Investment Capital Preservation Plans - baoquankhu1.vn

Apr 13, 2026

Bond Watch: Can Apollomics Inc Equity Warrant expand its profit marginsEarnings Miss & Smart Swing Trading Techniques - baoquankhu1.vn

Apr 13, 2026

Apr 11, 2026

Aug Wrap: Will Apollomics Inc Equity Warrant outperform the market in YEARJobs Report & Long Hold Capital Preservation Tips - baoquankhu1.vn

Apr 11, 2026

Apr 10, 2026

Risk Off: Is Apollomics Inc attractive at current valuation2026 Analyst Calls & Long-Term Capital Growth Ideas - baoquankhu1.vn

Apr 10, 2026

What happens to Apollomics (APLM) Stock after earnings | Price at $15.10, Up 1.68%Viral Trade Signals - Newser

Apr 10, 2026

Apr 09, 2026